GSK vs MRK: Which Stock is Better?
Side-by-side comparison of GlaxoSmithKline PLC ADR and Merck & Company Inc in 2026
GSK
GlaxoSmithKline PLC ADR
—
MRK
Merck & Company Inc
$127.50
Key Metrics Comparison
| Metric | GSK | MRK | Winner |
|---|---|---|---|
| Market Cap | $103.31B | $285.12B | MRK |
| P/E Ratio | 13.49 | 32.52 | GSK |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GSK
Full quant analysis
Analyze MRK
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GSK or MRK a better investment?
Comparing GSK and MRK: GlaxoSmithKline PLC ADR has a market cap of $103.31B while Merck & Company Inc has $285.12B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GSK and MRK?
GSK (GlaxoSmithKline PLC ADR) and MRK (Merck & Company Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GSK or MRK?
Based on P/E ratios, GSK trades at a lower multiple (13.5x vs 32.5x).
Which is growing faster: GSK or MRK?
Both GSK and MRK show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GSK or MRK?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GSK or MRK?
Merck & Company Inc (MRK) is larger with a market cap of $285.12B compared to $103.31B for GSK.
Should I buy GSK or MRK in 2026?
Both GSK and MRK have investment merit. GSK trades at $N/A while MRK trades at $127.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GSK and MRK stock?
Key differences: Market Cap ($103.31B vs $285.12B), P/E Ratio (13.5x vs 32.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GSK or MRK in 2026?
The choice between GSK and MRK depends on your investment goals. MRK shows higher revenue growth (0.0%). MRK has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GSK and MRK?
GSK (GlaxoSmithKline PLC ADR) has a market cap of $103.31B, while MRK (Merck & Company Inc) has a market cap of $285.12B. MRK is the larger company by market value.